Kumar Vedantham
Purdue University
7 Papers
25 Citations
Kumar Vedantham is an academic researcher from Purdue University. The author has contributed to research in topics: Drug carrier & Cancer. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Kumar Vedantham include University of North Carolina at Charlotte & University of North Carolina at Chapel Hill.
Chat about Author
Papers
A study of drug release from homogeneous PLGA microstructures
Ghanashyam Acharya,Crystal S. Shin,Kumar Vedantham,Matthew D. McDermott,Thomas Rish,Keith S. Hansen,Yourong Fu,Kinam Park +7 more
TL;DR: The hydrogel template method was used to fabricate homogeneous drug-PLGA microparticles of homogeneous size and shape, expected to provide better prediction and reproducibility of the drug release property of a given formulation.
103
A ceramic-based anticancer drug delivery system to treat breast cancer
Ahmed El-Ghannam,Krista Ricci,Ahmed Malkawi,Kiarash Jahed,Kumar Vedantham,Heather Wyan,Lauren D Allen,Didier Dréau +7 more
TL;DR: The results strongly suggest that SCPC/5-FU hybrids can provide an effective treatment for solid tumors with minimal side effects.
38
Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections
TL;DR: The potential of SCPC75-Vanc-rhBMP2 scaffolds in the treatment of damaged and/or infected bone is suggested and differences in drug release kinetics and bioceramic dissolution rate were found.
32
Drug-Eluting Stent for Delivery of Signal Pathway-Specific 1,3-Dipropyl-8-cyclopentyl Xanthine
TL;DR: A(1)R specific antagonist DPCPX was effective in preventing CASMC proliferation and holds great promise for intracoronary delivery from DESs to test the role of the A( 1)R signaling pathway for prevention of in-stent restenosis.
Future outlook for drug eluting stents
Kumar Vedantham,Somali Chaterji,J. Kitsongsermthon,Kinam Park,John Garner +4 more
- 01 Jan 2010
TL;DR: The chapter begins by addressing mechanisms of restenosis and various platforms for DES that has been developed before to overcome these complications, and the shortcoming of DES with respect to thrombosis has been critically reviewed, while providing an insight about the future of DES.
10